Abstract
Antitumor Effects of Dihydromyricetin and Bevacizumab on SKOV-3 Ovarian Cancer Cell Line
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Zenodo (CERN European Organization for Nuclear Research)
Paper Title
Journal
Date